Document is current
Any future updates will be listed below
-
Authors
Sarti, Alba Clara
Vultaggio-Poma, Valentina
Di Virgilio, Francesco https://orcid.org/0000-0003-3566-1362
- License Information
-
More Information
Article History
Received: 18 March 2021
Accepted: 21 March 2021
First Online: 5 April 2021
Compliance with ethical standards
:
: FDV is a member of the Scientific Advisory Board of Biosceptre Ltd, a Biotech Company involved in the development of P2X7-targeting antibodies.Alba Clara Sarti declares that she has no conflict of interest.Valentina Vultaggio-Poma declares that she has no conflict of interest.
: This article does not contain any studies with human participants or animals performed by any of the authors.
